A comparison of two treatment regimens of ceftriaxone in late Lyme disease. - Wikidata - awgldk - TriplyDB

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

http://www.wikidata.org/entity/Q46625674

about

Chronic Lyme disease Chronic Lyme disease: a review Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide Chronic Lyme disease: the controversies and the science.Antiscience and ethical concerns associated with advocacy of Lyme disease.Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)--design of a randomized controlled trial of prolonged antibiotic treatment in patients with persistent symptoms attributed to Lyme borreliosis Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients.Generalizability in two clinical trials of Lyme disease.Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis Lyme disease and the orthopaedic implications of lyme arthritis.Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures.Management of Lyme disease.Management of neuroborreliosis in European adult patients.Natural killer cells and natural killer T cells in Lyme arthritis.Treatment of infection caused by Borrelia burgdorferi sensu lato.Diagnosis and treatment of Lyme arthritis.Antibiotics for the neurological complications of Lyme disease.Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life.First Case of Lyme Arthritis Involving a Prosthetic Knee Joint.[Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].Is there a place for xenodiagnosis in the clinic?Lyme disease: clinical diagnosis and treatment.Lyme borreliosis

P2860

Q22252195-16893585-3A3D-4BD7-A788-91DC8BFBF6AC Q22252200-32D32565-2EE1-405A-96BB-51AA84E05E51 Q24630127-8E7CC0F1-7834-472E-AC47-7537AD0D7DE2 Q34205531-8A712A07-246A-4618-B0C9-FC25CD2634CF Q34210918-143894AA-5F6C-4E5E-897C-53B4CCBA1502 Q34374899-D252B250-D11B-444F-985B-AD2A75DFFEB7 Q34379684-287FC17F-CBDF-4838-88B5-4A8E1576AF7B Q34574254-173508CA-0BCF-427C-9FB4-26D3A600331B Q35019816-A8027588-F0FF-4E0C-A48A-2EA96AB7E04D Q36138254-7A85AFC8-CC59-4A19-86C1-B4778C13860F Q36850934-69378961-D13E-4F39-A238-256F4A3D7D7B Q36902069-1A1BFC3F-77E8-4B80-8F0D-00C0201F0DD8 Q36948131-B696721A-ED84-40EB-B93A-7F74D7674F79 Q37124900-EA13666D-5C19-4681-8FB7-3EEAF973A3FD Q37148487-0139941D-7E88-4108-9F6B-D383B631538E Q37690359-824EBEE8-3157-4924-A196-47D940E2096F Q37845853-5A650A2C-2E89-4644-A187-9C1D35842355 Q38496896-9A98A2D6-2FB0-43AE-B6E2-F73146A102E4 Q39032987-85A03BA5-D299-4DA2-91E2-C90F3A08FF6F Q40086395-EB7AFDF1-AF22-4574-A2F0-F7805A0F6A00 Q40612503-5E0B542B-56E9-476A-8643-32310442CEBA Q43405533-A894CA5E-1066-4CD0-A74B-D112C09CFDC4 Q47886219-22B2EB2B-20F8-40B1-BBDE-0B58DDC4E964 Q55284263-0D3AE5E5-93E1-4769-A07F-52AFD84B4491 Q56764150-578BD865-3E34-4243-9AE6-5CD068EE2BDD

P2860

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

http://www.wikidata.org/entity/Q46625674

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@en

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@nl

type

label

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@en

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@nl

prefLabel

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@en

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@nl

P1433

Q46625674-EA23BA17-87FC-40D9-8FE1-D5751F74530E

P1476

Q46625674-B6E95592-D142-40C7-800E-FB5E50964F98

P2093

Q46625674-038C883F-DEA7-4D4A-A358-FA86463A6608

Q46625674-2B129B08-BFAD-432E-82F9-E2275F91BB50

Q46625674-2D40F374-9733-4302-ACA9-370987E7D340

Q46625674-3AB7D567-FDEB-4A48-B4FF-FC7113D056B5

Q46625674-654500D9-3A59-4BC9-96C3-C7D238167734

Q46625674-86FCE17A-1039-4D0C-BC0E-59F19AC7E1CC

Q46625674-8C930F55-6795-4344-B19D-5F9AA1C4A7B2

Q46625674-9B829787-59C6-4D60-8E9A-0B92900F380A

Q46625674-ABB20086-4590-4254-87EE-713D377134F2

Q46625674-B7192E78-32F9-44CC-8527-97AE6D58CE4D

P2888

Q46625674-8B286841-E869-48C9-BFD7-64F2D5503B7F

P304

Q46625674-939B5DF0-195D-4EF8-9729-AA0B8BB4F948

P31

Q46625674-1E64266B-17DA-4AE4-93E7-60C99C445651

P356

Q46625674-1FFEE872-767E-4EEF-85BC-C7FD488D6F8C

P433

Q46625674-AB736BC0-7D20-4F46-B5BA-DB1CED130708

P478

Q46625674-D72709C3-3054-44D2-AAE9-504D3D7FE8F7

P50

Q46625674-54C518B6-0B35-4C6D-9417-E20250073487

P577

Q46625674-A3F07C28-2525-418C-88CB-F35F6DB73FA6

P698

Q46625674-E0695D31-85A4-4EB2-924D-E90D56B2BE6E

P921

Q46625674-770DE2C0-2917-479E-9199-5BE960A2055E

P356

S00508-005-0361-8

P1433

Wiener Klinische Wochenschrift

P1476

A comparison of two treatment regimens of ceftriaxone in late Lyme disease.

@en

P2093

Dionigi Maladorno

http://www.w3.org/2001/XMLSchema#string

Edgar Grunwaldt

http://www.w3.org/2001/XMLSchema#string

Eileen Hilton

http://www.w3.org/2001/XMLSchema#string

Gary L Bryant

http://www.w3.org/2001/XMLSchema#string

Gary P Wormser

http://www.w3.org/2001/XMLSchema#string

Michael F Finkel

http://www.w3.org/2001/XMLSchema#string

Michael Franklin

http://www.w3.org/2001/XMLSchema#string

Robert T Schoen

http://www.w3.org/2001/XMLSchema#string

Thomas J Rush

http://www.w3.org/2001/XMLSchema#string

William A Agger

http://www.w3.org/2001/XMLSchema#string

P2888

s00508-005-0361-8

P304

393-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00508-005-0361-8

http://www.w3.org/2001/XMLSchema#string

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P50

Raymond J. Dattwyler

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16053194

http://www.w3.org/2001/XMLSchema#string

P921